S

Sphere Fluidics Limited

61 employees

Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
cancer
Life Science
single cell analysis
biotechnology
immunology
cells
enzymes
droplets
immunotherapy
oncology
life sciences
pharmaceutical
cell therapies
genome editing
lab-on-a-chip
biopharmaceutical
stem cells
microfluidics
antibodies
biologics

Date founded

2010

Funding rounds raised

Total raised

$41M

from 17 investors over 17 rounds

S

Sphere Fluidics Limited raised $41M on October 28, 2021

Investors: Sofinnova Partners and Redmile Group

S

Sphere Fluidics Limited raised $4.8M on June 10, 2019

Investors: Oxford Investment Consultants LLP and 24Haymarket

S

Sphere Fluidics Limited raised $1.3M on July 17, 2017

Investors: Twist Bioscience, Innovate UK and The University of Edinburgh

S

Sphere Fluidics Limited raised $7M on February 10, 2016

Investors: Parkwalk Advisors, 24Haymarket and Newable Private Investing

S

Sphere Fluidics Limited raised $2.4M on June 24, 2014

Investors: QVentures and Parkwalk Advisors

S

Sphere Fluidics Limited raised $2.5M on February 19, 2013

Investors: Amadeus Capital Partners, Parkwalk Advisors, Cambridge Angels and Newable Private Investing

S

Sphere Fluidics Limited raised undisclosed on June 1, 2012

Investors: Newable Private Investing

FAQ